In re: Perrigo-Manufactured Glucosamine Products Marketing & Sales Practices Litigation
This text of 11 F. Supp. 3d 1333 (In re: Perrigo-Manufactured Glucosamine Products Marketing & Sales Practices Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
[1334]*1334ORDER DENYING TRANSFER
Before the Panel:
Plaintiffs in the Southern District of New York action {Quinn) oppose centralization. Defendants Walgreen Co. (Wal-greens), Wal-Mart Stores, Inc., and Su-pervalu, Inc., submitted a joint response also opposing centralization.2
On the basis of the papers filed and the hearing session held, we will deny the motion. We are not persuaded that Section 1407 centralization at this time would serve the convenience of the parties and witnesses or promote the just and efficient conduct of the litigation. Two days before oral argument in this matter, counsel for the Quinn plaintiffs and defense counsel informed us that they had reached a “global” settlement that they expect will resolve all of the subject actions. They stated that they, along with counsel for the Southern District of California Eckler and Northern District of Illinois Guilin plaintiffs, had “begun papering the settlement,” and that they anticipated “being in a position to seek preliminary approval in short order.” In these circumstances, we conclude that centralization might delay proceedings related to the proposed settlement, as well as create additional burdens for the involved litigants and courts with little offsetting benefit.3 See In re: Pilot Flying J Fuel Rebate Contract Litig., 959 F.Supp.2d 1373, 1374 (J.P.M.L.2013); accord In re: Power Balance, LLC, Mktg. & Sales Practices Litig., 777 F.Supp.2d 1345, 1345-46 (J.P.M.L.2011). If certain plaintiffs wish to object to or opt out of the proposed settlement, there are suitable mechanisms in place by which they may do so without the need for an MDL. See In re: Pilot Flying J, 959 F.Supp.2d at 1374.
IT IS THEREFORE ORDERED that pursuant to 28 U.S.C. § 1407, the motion for centralization of these actions is denied.
SCHEDULE A
MDL No. 2518 — IN RE: PERRIGO-MANUFACTURED GLUCOSAMINE PRODUCTS MARKETING AND SALES PRACTICES LITIGATION
Southern District of California
ECKLER V. WAL-MART STORES, INC, C.A. No. 3:12-00727 NUNEZ V. SUPERVALU, INC., ET AL., C.A. No. 3:13-00626
District of Delaware
NELSON V. WALGREEN CO., C.A. No. 1:13-01871
Southern District of Florida
GROUP V. WALGREEN CO., C.A. No. 9:13-81105
Northern District of Illinois
GUILIN V. WALGREENS COMPANY, C.A. No. 1:11-07763
[1335]*1335 District of New Jersey
GROSS V. WALGREEN CO., C.A. No. 1:13-06630
Southern District of New York
QUINN, ET AL. V. WALGREEN CO., C.A. No. 7:12-08187
Western District of Pennsylvania
CALVERT V. WALGREEN CO., C.A. No. 2:13-01161
Judge Maijorie O. Rendell and Judge Lewis A. Kaplan took no part in the decision of this matter.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
11 F. Supp. 3d 1333, 2014 U.S. Dist. LEXIS 46607, 2014 WL 1338423, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-perrigo-manufactured-glucosamine-products-marketing-sales-jpml-2014.